Desvenlafaxine Extended-Release Tablets
Devtic ER 50 mg and 100 mg (Desvenlafaxine Extended-Release Tablets) are serotonin–noradrenaline reuptake inhibitors (SNRIs) used to treat major depressive disorder. Desvenlafaxine is the active metabolite of venlafaxine. By selectively blocking the reuptake of serotonin and noradrenaline, it helps restore chemical balance in brain pathways that regulate mood, energy, sleep and appetite. The extended-release design delivers the medicine slowly over 24 hours for steadier blood levels with once-daily dosing, which can improve symptom control and reduce peaks and troughs that may cause side effects. Some people may notice temporary nausea, dry mouth, dizziness, headache, increased sweating, constipation, reduced appetite, insomnia or sleepiness, and sexual side effects. Take the tablets exactly as prescribed and speak with your doctor if side effects persist or become troublesome.
Devtic-ER 50/100 are indicated for the treatment of major depressive disorder in adults. By improving serotonin and noradrenaline signaling, they help reduce low mood, loss of interest, fatigue, poor concentration, sleep disturbance and other depressive symptoms. Your clinician may consider them when a once-daily, extended-release SNRI is appropriate.